Leadership Overview
Jazz Pharmaceuticals has 6 executives leading key functions including corporate strategy, financial operations, commercial planning, medical oversight, human resources, and research development.
Focused on transforming lives through innovative medicine, Jazz Pharmaceuticals advances global health by addressing serious diseases with limited treatment options through neuroscience and oncology expertise.
Focused on transforming lives through innovative medicine, Jazz Pharmaceuticals advances global health by addressing serious diseases with limited treatment options through neuroscience and oncology expertise.
Leadership Roles at Jazz Pharmaceuticals
Bruce Cozadd - Chairperson and Chief Executive Officer
Bruce Cozadd, the Chairperson and Chief Executive Officer at Jazz Pharmaceuticals, directs the overarching corporate strategy and long-term vision for the global biopharmaceutical organization. Overseeing the integration of internal R&D with strategic licensing partnerships, the Chairperson and Chief Executive Officer ensures the company maintains a competitive edge in neuroscience and oncology markets. This leadership role involves constant engagement with the Board to align business objectives with patient needs across North American and European operations. By prioritizing the development of medicines for serious diseases, Bruce Cozadd drives the expansion of the product portfolio. The Chairperson and Chief Executive Officer manages the executive team to ensure operational excellence and financial sustainability. Through rigorous oversight of corporate governance and market expansion, Cozadd secures the future trajectory of the firm while fostering a culture of innovation and scientific advancement within the global pharmaceutical landscape.
Taryn Stinson - Director, Chief of Staff To the Chief Financial Officer
Taryn Stinson, the Director, Chief of Staff To the Chief Financial Officer at Jazz Pharmaceuticals, manages the strategic initiatives and operational workflows within the finance department. Coordinating closely with the Chief Financial Officer, the Director, Chief of Staff To the Chief Financial Officer optimizes resource allocation and financial planning processes to support global biopharmaceutical growth. This role involves analyzing complex fiscal data to inform decision-making regarding acquisitions and R&D investments. By streamlining communication between the finance division and other executive functions, Taryn Stinson ensures alignment with corporate financial goals. The Director, Chief of Staff To the Chief Financial Officer monitors performance metrics across international manufacturing facilities to maintain fiscal discipline. Through the implementation of efficient reporting structures, Stinson enhances the transparency and accuracy of financial operations, ultimately supporting the long-term stability and market impact of the organization in the competitive pharmaceutical sector.
Jessica Ungerleider - Commercial Strategy & Planning Chief of Staff
Jessica Ungerleider, the Commercial Strategy & Planning Chief of Staff at Jazz Pharmaceuticals, architects the tactical frameworks necessary for successful product commercialization in neuroscience and oncology. Overseeing the alignment of commercial objectives with market demand, the Commercial Strategy & Planning Chief of Staff drives the execution of launch plans for new therapies. This leadership position requires constant collaboration with cross-functional teams to ensure that patient access remains a priority across global markets. By evaluating market trends and competitive landscapes, Jessica Ungerleider informs the strategic direction of the commercial division. The Commercial Strategy & Planning Chief of Staff manages complex planning cycles to ensure that resources support the most critical therapeutic areas. Through the optimization of commercial processes, Ungerleider enhances the reach of life-changing medicines, ensuring that the company effectively addresses serious diseases with limited treatment options while maintaining a strong, sustainable market presence.
Arthur Louie - Chief Medical Officer
Arthur Louie, the Chief Medical Officer at Jazz Pharmaceuticals, directs the clinical development and medical affairs strategy for the company's neuroscience and oncology portfolios. Overseeing the rigorous evaluation of clinical trial data, the Chief Medical Officer ensures that all therapeutic candidates meet the highest standards of safety and efficacy. This role involves leading medical engagement with global regulatory bodies to facilitate the approval and distribution of medicines for serious diseases. By providing scientific leadership, Arthur Louie guides the organization through complex clinical development phases. The Chief Medical Officer collaborates with internal research teams to translate scientific discoveries into viable treatment options for patients with limited alternatives. Through the management of medical strategy, Louie ensures that clinical outcomes align with the broader mission of the firm. This leadership function remains critical to the successful advancement of the pipeline and the overall medical credibility of the company in international markets.
Heidi Manna - Executive VP & Chief People Officer
Heidi Manna, the Executive VP & Chief People Officer at Jazz Pharmaceuticals, architects the human capital strategy to support a global workforce dedicated to biopharmaceutical innovation. Overseeing talent acquisition, organizational development, and employee engagement, the Executive VP & Chief People Officer ensures that the company attracts and retains top-tier scientific and commercial talent. This role involves fostering a culture of inclusion and high performance across international offices and manufacturing facilities. By aligning workforce capabilities with the strategic goals of the organization, Heidi Manna drives operational efficiency and employee satisfaction. The Executive VP & Chief People Officer collaborates with the executive leadership team to implement policies that promote professional growth and organizational agility. Through the management of human resources, Manna ensures that the company maintains the necessary expertise to advance its portfolio in neuroscience and oncology, ultimately supporting the long-term success and mission-driven culture of the entire enterprise.
Robert Iannone - Executive VP, Global Head of Research & Development & Chief Medical Officer
Robert Iannone, the Executive VP, Global Head of Research & Development & Chief Medical Officer at Jazz Pharmaceuticals, directs the entire R&D pipeline and medical strategy for the organization. Overseeing the discovery and development of new therapies for hematologic malignancies and solid tumors, the Executive VP, Global Head of Research & Development & Chief Medical Officer ensures that scientific innovation remains at the core of the business model. This role involves managing complex licensing partnerships and internal research initiatives to expand the therapeutic portfolio. By leading the scientific team, Robert Iannone accelerates the transition of candidates from laboratory research to clinical application. The Executive VP, Global Head of Research & Development & Chief Medical Officer coordinates with global regulatory agencies to ensure compliance and timely delivery of medicines. Through the strategic oversight of R&D, Iannone drives the company's ability to address serious diseases, maintaining a robust pipeline that supports long-term growth and patient impact.
Explore Leadership Teams in Manufacturing
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's pharmaceutical division focuses on developing and manufacturing prescription medicines across major therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The diagnostics division provides a comprehensive range of products and services for early detection, prevention, diagnosis, and management of diseases, spanning laboratory diagnostics, tissue diagnostics, and diabetes care. Roche is committed to personalized healthcare, pioneering the development of targeted therapies and companion diagnostics that enable treatment decisions tailored to individual patients. The company invests heavily in research and development, maintaining a robust pipeline of innovative medicines and diagnostic solutions while collaborating with academic institutions, biotechnology companies, and healthcare partners worldwide. Headquartered in Basel, Switzerland, Roche operates globally with a presence in numerous countries, employing a diverse workforce of scientists, researchers, healthcare professionals, and business experts dedicated to transforming patient care and making a meaningful difference in the fight against serious diseases.
Company Leadership TH
AH
CB
Dexcel Pharma is Israel’s largest privately owned pharmaceutical company, founded in 1968 and headquartered in Or Akiva. It develops, manufactures, and commercializes value‑added branded prescription drugs, generics, and OTC products—primarily oral solid dosage forms—supplying more than 85 products in over 175 dosage forms to markets including the U.S., U.K., Germany, Austria, and others through subsidiaries and distribution partners.
Company Leadership DO
UO
Hemofarm is the leading pharmaceutical company in Serbia and in the region. Care for your health is the company's most important commitment. Hemofarm is a leader in the Serbian pharmaceutical market with a 17.3% share in financial terms. Holding a 79.1% share in the export of Serbian pharmaceutical products, the Vrac-based company is at the same time the leading Serbian exporter of medicinal products. Hemofarm produces over 4 billion tablets and capsules a year.
Company Leadership DS
TM
VA
Emcure Pharmaceuticals Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products and healthcare solutions. Headquartered in Pune, India, the organization operates as an international pharmaceutical enterprise with a strong presence in both domestic and global healthcare markets. The company focuses on delivering innovative and affordable medicines that address a wide spectrum of medical conditions and therapeutic needs across the healthcare sector. The organization is driven by a research-focused strategy that emphasizes innovation, scientific advancement, and the development of effective therapeutic solutions. Through its research and development capabilities, Emcure Pharmaceuticals works to discover and formulate medicines that address unmet medical needs and improve patient outcomes. The company’s research initiatives focus on areas such as complex generics, biosimilars, biologics, and specialized pharmaceutical formulations. These research efforts allow the organization to continuously introduce improved therapies and drug delivery systems designed to enhance treatment effectiveness and patient safety.
Company Leadership SM
MJ
TS
Frequently Asked Questions Regarding Jazz Pharmaceuticals Top Executives and Leadership Team
Unlock more people and company data
